Samuel Yamshon

Also affiliated with NYU Langone Health, Weill Cornell Medicine, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, New York University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function”.

EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function

Cancer Cell(2024)10.1016/j.ccell.2024.11.006

N/A

0DataRank · unranked

61 citations

Xi Chen, Matt Teater, Ioannis Karagiannidis, Henna S. Nam, Winson Cai +20 more

Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study

American Journal of Hematology(2025)10.1002/ajh.27630

N/A

0DataRank · unranked

10 citations

Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos +25 more